Pantoprazole Sodium Delayed-release Suspension
Product Images NDC 69097-531

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium Delayed-release (NDC 69097-531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (A10b8d15 6e65 486c 8765 8167604b3ff5 01)

Chemical structure of pantoprazole sodium showing its molecular components including a benzimidazole ring, a sulfoxide group, and a sodium ion. The structure includes a fluorinated phenyl ring and represents the hydrate form with 1.5 water molecules (H2O).*

FDA Label Image

Sachet Label (A10b8d15 6e65 486c 8765 8167604b3ff5 02)

Label for PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release oral suspension, 40 mg/1, from Cipla USA Inc. The label includes text and a designated area for batch overprinting. The layout indicates it is designed for packaging or bottle labeling with printing guides and orientation marks.*

FDA Label Image

Carton (A10b8d15 6e65 486c 8765 8167604b3ff5 03)

Packaging label for Pantoprazole Sodium Delayed-Release Oral Suspension 40 mg by Cipla USA Inc. The label states the product contains 30 packets of granules for delayed-release oral suspension, intended to be mixed with apple juice or applesauce. It includes dosage instructions, storage conditions, and manufacturer information. The NDC is 69097-531-53.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.